mRNA-1365

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1365, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months [Phase 1]

See pricing